184 related articles for article (PubMed ID: 31277475)
1. Association of lncRNA
Wu ER; Chou YE; Liu YF; Hsueh KC; Lee HL; Yang SF; Su SC
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31277475
[TBL] [Abstract][Full Text] [Related]
2. The association of polymorphisms in lncRNA-
Yang ML; Huang Z; Wang Q; Chen HH; Ma SN; Wu R; Cai WS
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29511035
[TBL] [Abstract][Full Text] [Related]
3. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
Song Y; Xing H; Zhou L; Zhang N; Yang M
Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
[TBL] [Abstract][Full Text] [Related]
4. Association between genetic polymorphisms of long noncoding RNA H19 and cancer risk: a meta-analysis.
Hashemi M; Moazeni-Roodi A; Sarabandi S; Karami S; Ghavami S
J Genet; 2019 Sep; 98():. PubMed ID: 31544800
[TBL] [Abstract][Full Text] [Related]
5. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population.
Yang C; Tang R; Ma X; Wang Y; Luo D; Xu Z; Zhu Y; Yang L
Oncotarget; 2015 Jun; 6(17):15311-20. PubMed ID: 25944697
[TBL] [Abstract][Full Text] [Related]
6. The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma.
Wang YC; Tsao SM; Li YT; Lee CY; Tsao TC; Hsieh MJ; Yang SF
Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33799753
[TBL] [Abstract][Full Text] [Related]
7. Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma.
Su SC; Hsieh MJ; Chou YE; Fan WL; Yeh CB; Yang SF
Medicine (Baltimore); 2015 Aug; 94(34):e1396. PubMed ID: 26313784
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA H19 rs217727 polymorphism is associated with PE susceptibility.
Harati-Sadegh M; Kohan L; Teimoori B; Salimi S
J Cell Biochem; 2018 Jul; 119(7):5473-5480. PubMed ID: 29380421
[TBL] [Abstract][Full Text] [Related]
9. Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis.
Yang M; Zhang M; Wang Q; Guo X; Geng P; Gu J; Ji W; Zhang L
BMC Cancer; 2023 Jul; 23(1):688. PubMed ID: 37480014
[TBL] [Abstract][Full Text] [Related]
10. Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Wang B; Hsu CJ; Lee HL; Chou CH; Su CM; Yang SF; Tang CH
Int J Med Sci; 2018; 15(6):653-658. PubMed ID: 29725257
[TBL] [Abstract][Full Text] [Related]
11. Association of the study between LncRNA-H19 gene polymorphisms with the risk of breast cancer.
Abdollahzadeh S; Ghorbian S
J Clin Lab Anal; 2019 Mar; 33(3):e22826. PubMed ID: 30485527
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.
Huang WS; Lin HY; Yeh CB; Chen LY; Chou YE; Yang SF; Liu YF
Int J Med Sci; 2017; 14(2):136-142. PubMed ID: 28260989
[TBL] [Abstract][Full Text] [Related]
13. Association of lncRNA
Wu ER; Hsieh MJ; Chiang WL; Hsueh KC; Yang SF; Su SC
Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31398859
[TBL] [Abstract][Full Text] [Related]
14. Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study.
Li Y; He HC; Zhou DL; Liu Q; Zhang X; Yang XH; Ye ZL; Peng JL; Tang T; Su X; He CY
J Gastroenterol Hepatol; 2021 Jan; 36(1):233-239. PubMed ID: 32453900
[TBL] [Abstract][Full Text] [Related]
15. Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population.
Li Z; Niu Y
Minerva Urol Nefrol; 2019 Apr; 71(2):161-167. PubMed ID: 29595036
[TBL] [Abstract][Full Text] [Related]
16. Significant association between lncRNA H19 polymorphisms and cancer susceptibility: a meta-analysis.
Li XF; Yin XH; Cai JW; Wang MJ; Zeng YQ; Li M; Niu YM; Shen M
Oncotarget; 2017 Jul; 8(28):45143-45153. PubMed ID: 28404885
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological characteristic associations of long non-coding RNA gene H19 polymorphisms with uterine cervical cancer.
Huang MC; Chou YH; Shen HP; Ng SC; Lee YC; Sun YH; Hsu CF; Yang SF; Wang PH
J Cancer; 2019; 10(25):6191-6198. PubMed ID: 31772651
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Long Noncoding RNA H19 Polymorphisms and Risk of Coronary Artery Disease in a Chinese Population: A Case-Control Study.
Hu WN; Ding HX; Xu Q; Zhang XY; Yang DT; Jin YZ
Dis Markers; 2020; 2020():9839612. PubMed ID: 32454910
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the H19 gene and the risk of lung Cancer among female never smokers in Shenyang, China.
Yin Z; Cui Z; Li H; Li J; Zhou B
BMC Cancer; 2018 Sep; 18(1):893. PubMed ID: 30219045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
